Table 2.
Multivariate logistic regression analysis of factors influencing CVC in MHD patients.
| Factor | β | S.E. | Wald | Degrees of freedom | P | OR | 95% CI | |
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| Age | 0.034 | 0.015 | 4.899 | 1.000 | 0.027 | 1.035 | 1.004 | 1.066 |
| Sex (Male) | −0.193 | 0.302 | 0.408 | 1.000 | 0.523 | 0.825 | 0.456 | 1.492 |
| VFA | 0.020 | 0.007 | 9.479 | 1.000 | 0.002 | 1.020 | 1.007 | 1.034 |
| iPTH | 0.003 | 0.001 | 6.212 | 1.000 | 0.013 | 1.003 | 1.001 | 1.005 |
| Hs-CRP | 0.018 | 0.011 | 2.647 | 1.000 | 0.104 | 1.018 | 0.996 | 1.041 |
| Serum phosphorus | 0.205 | 0.129 | 2.527 | 1.000 | 0.112 | 1.227 | 0.953 | 1.580 |
| HDL-C | −0.621 | 0.351 | 3.132 | 1.000 | 0.077 | 0.537 | 0.270 | 1.069 |
| Primary diseasea | 0.412 | 0.288 | 2.042 | 1.000 | 0.153 | 1.509 | 0.857 | 2.658 |
| Comorbid diabetes | 0.929 | 0.366 | 6.430 | 1.000 | 0.011 | 2.531 | 1.235 | 5.189 |
a
Primary disease refers to diabetic nephropathy.
VFA, visceral fat area; iPTH, intact parathyroid hormone.